Collecting blood and stool samples to detect colorectal cancer in Lynch syndrome patients
Official title: Detection of Colorectal Cancer or Advanced Neoplasia by Stool DNA in Lynch Syndrome: CORAL Study
Run by Mayo Clinic · NCT05410977 · Data updated 2026-11-12
This study is testing a new stool DNA test to see if it can help find colorectal cancer in people with Lynch syndrome by collecting their blood and stool samples.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 950 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 9 sites (Scottsdale, Arizona and 8 other locations) |
| Status | Recruiting |
| Started | March 30, 2022 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT05410977 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults diagnosed with Lynch syndrome or those with early onset colorectal cancer under the age of 50.
✕Probably not a fit
Patients with known cancer stages I-IV or those who have received certain cancer treatments in the past five years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of a multitarget stool DNA test for detecting colorectal neoplasia in patients with Lynch syndrome. Participants will provide blood and stool samples, which will be collected within a specific timeframe around their scheduled colonoscopy or flexible sigmoidoscopy. The study also seeks to create a biorepository of these samples for future research. Medical records of the participants will be reviewed to gather additional data.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection of colorectal cancer in patients with Lynch syndrome, potentially saving lives.
How similar studies have gone: Other studies have shown promise in using DNA screening techniques for cancer detection, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients at least 18 years of age * Individuals diagnosed with Lynch syndrome (mutation in MLH1, MSH2, MSH6, PMS2, EPCAM) or colorectal cancer (CRC) with suspected Lynch syndrome or individuals diagnosed with early onset CRC (\<55 years old) * Colonoscopy/flexible sigmoidoscopy (flex sig) scheduled +/- 90 days from sample collection * Patient has agreed to participate and has signed the study consent form Exclusion Criteria: * Patient has known cancer (stage I-IV) within 5 years prior to current sample collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible) * Patient has received chemotherapy class drugs for the treatment of cancer in the 5 years prior to current sample collection * Patient has had any abdominal radiation therapy prior to current sample collection * Patient had therapy to the target (non-hyperplastic) lesion with intent to completely remove or debulk the lesion prior to sample collection \[examples include snare polypectomy, endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), surgical resection, trans anal excision\] * Patient has prior diagnosis of non-lynch hereditary colon cancer syndrome \[familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), Peutz-Jeghers syndrome (PJS), juvenile polyposis syndrome (JPS), PTEN, POL\] * ADDITIONAL STOOL EXCLUSIONS: * Bowel prep \<7 days prior to stool collection * Oral or rectal contrast given within 7 days prior to stool collection * Presence of ileostomy * Enteral feeds or total parenteral nutrition (TPN) * Diagnosis of inflammatory bowel disease
Where it's running
-
Mayo Clinic in Arizona
Scottsdale, Arizona, United States Recruiting -
University of Colorado Anschutz Medical Center
Aurora, Colorado, United States Recruiting -
Mayo Clinic in Florida
Jacksonville, Florida, United States Recruiting -
Dana Farber Cancer Institute
Boston, Massachusetts, United States Recruiting -
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting
Show 3 more locations
-
University of Washington
Seattle, Washington, United States Recruiting -
University of California San Francisco
San Francisco, California, United States Completed -
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Not yet recruiting
Study contacts
- Principal investigator: Niloy Jewel Samadder, M.D. — Mayo Clinic
- Study coordinator: Rosalie Himle
- Email: LaMere.Rosalie@mayo.edu
- Phone: 507-266-5755
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise after pelvic radiation to see if it lowers colorectal cancer risk
This study tests whether regular walking therapy after pelvic radiation for prostate cancer can influence markers of colorectal cancer in colon tissue and blood.
-
Irreversible Electroporation for Recurrent Pelvic Tumors
This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.
-
Smart Symptom Tracking with ALEX for GI Health in Young Adults
This trial tests whether the Smart Symptom Tracking ALEX app can better track GI symptoms in young adults (18–44) compared with standard paper logs.
-
Capsule camera screening of the small intestine for people with Lynch syndrome
This project looks back at past small-bowel capsule endoscopy exams to see if they detect precancerous lesions or early cancer in people with Lynch syndrome.
-
Liquid biopsy and machine learning to detect early colorectal cancer, advanced adenomas, Lynch-related cancers, and residual disease
This project will test a blood-based liquid biopsy that uses microRNA signals and machine learning to detect colorectal cancer, advanced adenomas, Lynch-associated cancers, and molecular residual disease in people who have a colonoscopy.
-
Cutting down ultra-processed foods for people at high cancer risk
This project tests whether using the Open Food Facts smartphone app alongside nutrition education helps adults at high risk of cancer eat fewer ultra-processed foods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.